Nick Whitehead
Principal at B Capital Group
San Francisco, California
Overview
Work Experience
Senior Principal
2025 - Current
Principal
2022 - 2025
Investor
2018 - 2021
B Capital Group is a venture capital firm that backs global entrepreneurs in the field of information technology.
Board Observer
2024
Sift Healthcare is a data mining and predictive analytics technology.
Raised $36,038,500.00 from Rock River Capital Partners, Allos Ventures, First Trust Capital Partners and B Capital.
Board Member
2022
Positive Development is improving lives by helping develop the skills to connect with one’s self, family, and community.
Raised $50,191,355.00 from Difference Partners and Operator Partners.
Board Observer
2022
Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.
Raised $252,960,628.00 from Prime Therapeutics.
Board Observer
2022
PicnicHealth helps patients easily access their medical records and gives them the opportunity to contribute data to medical research.
Raised $97,000,000.00 from Felicis, Amplify Partners and B Capital.
Board Observer
2021
Lively is a modern Health Savings Account (HSA) platform for employers and individuals.
Raised $122,200,000.00 from B Capital, Costanoa Ventures and Titanium Ventures.
Investor
2021
Aetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.
Raised $203,600,000.00 from B Capital, Warburg Pincus, Foresite Capital, Flare Capital Partners and New Enterprise Associates.
Investor
2020
Centivo offers a digital health plan aimed at self-funded employers looking to provide employees with care.
Raised $226,400,000.00 from Ingleside Investors, Cox Enterprises, MemorialCare Innovation Fund, B Capital, F-Prime Capital and Cone Health Ventures.
Investor
2020
Innovaccer provides a data activation platform that aggregates, analyzes, and leverages healthcare data to deliver actionable insights.
Raised $379,100,000.00 from B Capital, Tiger Global Management, Whale Rock Capital Management, Avidity Partners, Mubadala Capital Ventures, Steadview Capital, Dragoneer Investment Group, M12 - Microsoft's Venture Fund, OMERS Growth Equity and Schonfeld Strategic Advisors.
Investor
2020
Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.
Raised $176,645,000.00 from Bill & Melinda Gates Foundation.